The story
In 1943 the Greek-born cytologist George Papanicolaou and the gynecologist Herbert Traut, working at Cornell University Medical College in New York, published a monograph showing that cells scraped from the cervix and examined under a microscope could reveal uterine and cervical cancer, often before any symptom appeared. The test became known as the Pap smear. A doctor takes a sample of cells, spreads it on a glass slide, stains it, and a trained technician looks for cells with abnormal shape and nuclei.
Papanicolaou had begun in the 1910s and 1920s by studying vaginal cells in guinea pigs to follow their reproductive cycle, then found the same method worked in women. In 1928 he reported that cancer cells could appear in such smears, but the medical world, which relied on tissue biopsy, paid little attention. A Romanian pathologist, Aurel Babes, independently reported a similar approach in 1927 and 1928. Papanicolaou's wife Andromache served as his first subject and assistant. His partnership with Traut, who knew the pathology of the cervix and could confirm the findings with biopsies, convinced clinicians. The compound microscope made it all possible, and a multicolor stain Papanicolaou developed made cell detail much easier to read.
The key insight was that cervical cancer does not appear overnight: abnormal cells appear for years before cancer invades, so catching them early lets doctors remove them. The American Cancer Society promoted the test from the late 1940s, and screening programs spread through the 1950s and later. In the United States, deaths from cervical cancer fell by more than half over the following decades, and countries with organized screening saw similar drops. In the 1980s Harald zur Hausen identified human papillomavirus (HPV) as the cause of most cervical cancers, which led to HPV testing and vaccines. Cervical cancer still kills about 350,000 women a year, mostly in poorer countries that lack screening.
Why it mattered
- Screening for precancer became a model for cancer prevention, showing that early detection in healthy people can save lives.
- The link between HPV and cervical cancer was found by researchers who built on the smear's observations of abnormal cells.
- HPV tests and the HPV vaccine, introduced in 2006, now build on Pap screening to prevent cervical cancer.
- Cytology, the study of single cells, grew into a standard branch of diagnostic medicine.
Sources
- George Papanicolaou: Development of the Pap Smear Weill Cornell Medicine Library
- Human papillomavirus and cancer WHO
Drafted by AI (Claude) from the sources above and checked against them by AI; no historian has reviewed this page. Spot a mistake? Suggest a correction. How pages are made
Community notes
Loading notes…